Literature DB >> 18181206

Huntington's disease phenocopies are clinically and genetically heterogeneous.

Edward J Wild1, Ese E Mudanohwo, Mary G Sweeney, Susanne A Schneider, Jon Beck, Kailash P Bhatia, Martin N Rossor, Mary B Davis, Sarah J Tabrizi.   

Abstract

Huntington's disease (HD) classically presents with movement disorder, cognitive dysfunction and behavioral problems but is phenotypically variable. One percent of patients with HD-like symptoms lack the causative mutation and are considered HD phenocopies. Genetic diseases known to cause HD phenocopies include HD-like syndromes HDL1, HDL2, and HDL4 (SCA17). HD has phenotypic overlap with dentatorubral-pallidoluysian atrophy, the spinocerebellar ataxias and neuroferritinopathy. Identifying the genetic basis of HD phenocopies is important for diagnosis and may inform the search for HD genetic modifiers. We sought to identify neurogenetic diagnoses in the largest reported cohort of HD phenocopy patients. Two hundred eighty-five patients with syndromes consistent with HD, who were HD expansion-negative, were screened for mutations in PRNP, JPH3, TBP, DRPLA, SCA1, SCA2, SCA3, FTL and FRDA. Genetic diagnoses were made in 8 subjects: we identified 5 cases of HDL4, 1 of HDL1 and 1 of HDL2. One patient had Friedreich's ataxia. There were no cases of DRPLA, SCA1, SCA2, SCA3, or neuroferritinopathy. HD phenocopies are clinically and genetically diverse and a definitive genetic diagnosis is currently possible in only a minority of cases. When undertaken, it should be clinically directed and patients and clinicians should be prepared for the low probability of reaching a genetic diagnosis in this group of patients. 2008 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181206     DOI: 10.1002/mds.21915

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  25 in total

Review 1.  Genetics of dementia.

Authors:  Henry L Paulson; Indu Igo
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

Review 2.  Huntington's disease: progress toward effective disease-modifying treatments and a cure.

Authors:  Carl D Johnson; Beverly L Davidson
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

Review 3.  Genetics of neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

4.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

5.  JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family.

Authors:  Susanne A Schneider; Kate E Marshall; Jianfeng Xiao; Mark S LeDoux
Journal:  Neurogenetics       Date:  2012-03-25       Impact factor: 2.660

6.  Clinical and genetic investigation of a Brazilian family with Huntington's disease.

Authors:  L A Agostinho; M Spitz; J S Pereira; C L A Paiva
Journal:  Funct Neurol       Date:  2016 Jul-Sep

7.  C9orf72 expansion as a possible genetic cause of Huntington disease phenocopy syndrome.

Authors:  Vladimir S Kostić; Valerija Dobričić; Iva Stanković; Vesna Ralić; Elka Stefanova
Journal:  J Neurol       Date:  2014-07-18       Impact factor: 4.849

Review 8.  Recent advances in genetics of chorea.

Authors:  Niccolò E Mencacci; Miryam Carecchio
Journal:  Curr Opin Neurol       Date:  2016-08       Impact factor: 5.710

9.  Genotype-phenotype analysis in inherited prion disease with eight octapeptide repeat insertional mutation.

Authors:  Martin Paucar; Fengqing Xiang; Richard Moore; Ruth Walker; Elisabeth Winnberg; Per Svenningsson
Journal:  Prion       Date:  2013-11-25       Impact factor: 3.931

10.  Genetic screening of Greek patients with Huntington’s disease phenocopies identifies an SCA8 expansion.

Authors:  G Koutsis; G Karadima; A Pandraud; M G Sweeney; R Paudel; H Houlden; N W Wood; M Panas
Journal:  J Neurol       Date:  2012-09       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.